Healthcare, consumer stocks drag European shares lower; Bayer surges

Dec 2 (Reuters) - European shares inched lower on Tuesday, slightly extending losses in the previous session, while Bayer surged after the U.S. administration supported the German pharmaceutical firm's court appeal.

The pan-European STOXX 600 .STOXX fell 0.1% to 574.48, as of 0809 GMT, set to extend Monday's industrials-led declines.

However, major regional bourses such as Germany .GDAXI and France .FCHI were up about 0.1% each.

Healthcare stocks led declines on the index, down 0.3%, weighed down by losses in heavyweights AstraZeneca AZN.L and Novo Nordisk NOVOb.CO.

However, Bayer BAYGn.DE jumping about 15% after U.S. President Donald Trump's administration urged the U.S. Supreme Court on Monday to take up the company's bid to block thousands of lawsuits claiming its Roundup weed-killer caused cancer, limited losses in the sector.

Consumer discretionary stocks such as luxury firms and automobile companies were also trading lower.

Meanwhile, Trump's special envoy, Steve Witkoff, and son-in-law Jared Kushner are scheduled to meet Russian President Vladimir Putin for talks on a possible Ukraine ceasefire.

Among individual stocks, FDJ United FDJU.PA slipped 4.2% after J.P.Morgan downgraded the lottery and online game operator's stock to "underweight".

Investors will now focus on the euro zone's flash inflation data for November due later in the day.